YOLFTbeta
XIAO FANG ORD A (SHH) EQSW Exp:

XIAO FANG ORD A (SHH) EQSW Exp:

603207 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

21.85CNY-0.40 (-1.80%)

Price History

Full chart

Market Stats

Previous Close22.25
Open22.24
Day Range21.76 – 22.36
52-Week Range20.98 – 32.82
Volume1.06M
Market Cap3.96B
P/E (TTM)20.91
Forward P/E0.00
EPS1.17
Dividend Yield4.37%
Beta0.02
50-Day Avg23.78
200-Day Avg26.12

About

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. produces and sells medicines in China and internationally. It offers medicines in the areas of gastroenterology, dermatology, orthopedics, ENT, and disinfection. It also engages in the family health management business. The company was founded in 1993 and is based in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Zhiguang Fang
  • Employees529
  • HeadquartersNo. 777 Hongzhu Road, Shanghai, China, 201411, China
  • Websitehttps://www.xf-pharma.com

Leadership

  • Mr. Zhiguang FangGM & Chairman · b. 1957
  • Ms. Xiaoxu LuoDeputy GM, CFO, Secretary & Director · b. 1989
  • Ms. Juan XuFinancial Manager & Accounting Supervisor · b. 1981
  • Mr. Yufeng YinMarketing Manager & Director · b. 1979
  • Mr. Jiachen FangDeputy GM & Director · b. 1988
  • Mr. Yunfei ZhaoChief Engineer · b. 1977
  • Ms. Ying CaoDeputy General Manager · b. 1983
  • Ms. Lili JiangAssistant to the Chairman · b. 1986
  • Ms. Ai'e JiangDeputy Factory Manager & Production Director · b. 1978
  • Mr. Zouqing YaoAssistant to the Chairman · b. 1983

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue401.77M456.89M471.87M474.58M525.28M
Growth (%)-+13.72%+3.28%+0.57%+10.68%
Cost of Revenue147.25M187.16M162.97M163.19M183.85M
Gross Profit254.52M269.73M308.90M311.39M341.43M
Gross Margin63.35%59.04%65.46%65.61%65.00%
Operating Expense103.51M65.44M76.17M77.27M101.06M
Operating Income151.01M204.29M232.73M234.12M240.37M
Operating Margin37.59%44.71%49.32%49.33%45.76%
EBITDA-209.85M240.45M242.35M243.94M
EBITDA Margin-45.93%50.96%51.06%46.44%
Net Income126.27M175.18M203.63M205.27M207.49M
Net Income Margin31.43%38.34%43.15%43.25%39.50%
R&D14.20M13.59M16.28M15.11M19.30M
R&D as % of Total Revenue3.53%2.97%3.45%3.18%3.67%
Interest Expense89.61K130.92K46.93K27.78K26.74K
Interest Expense % of Total Revenue0.02%0.03%0.01%0.01%0.01%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets386.02M463.30M712.65M1.40B1.24B
Total Liabilities156.92M90.94M132.70M168.21M146.71M
Total Equity229.11M372.36M579.95M1.23B1.09B
Cash44.81M58.66M285.54M883.43M647.59M

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow179.51M137.20M200.26M212.21M160.80M
Capital Expenditure12.48M61.59M80.15M83.94M54.24M
Free Cash Flow167.03M75.61M120.11M128.27M106.56M
Dividends Paid84.56M111.39M--353.23M
FCF to OCF93.05%55.11%59.98%60.44%66.27%
Dividend Paid to FCF50.63%147.33%--331.50%

Key Statistics & Ratios

Market Cap3.96B
Enterprise Value3.35B
Trailing P/E20.91
Forward P/E0.00
Price / Sales7.36
Price / Book3.51
EPS1.17
Book Value7.12
Revenue (TTM)537.42M
Gross Profit (TTM)328.63M
EBITDA222.90M
Profit Margin35.77%
Operating Margin41.15%
Return on Equity17.02%
Return on Assets10.73%
Shares Outstanding161.78M
Shares Float52.82M
Beta0.02
Dividend Yield4.37%
Dividend Rate1.07
Payout Ratio89.17%

Dividends

20262×
0.39Oct 20, 20260.37Jul 3, 2026
20252×
0.70Oct 20, 20251.50Jun 10, 2025